Clinical Trial Update: Pulmonary Vein Isolation To Reduce Future Risk Of Atrial Fibrillation In Patients Undergoing Typical Flutter [NA]

View source ↗

Summary

The trial investigating pulmonary vein isolation to reduce future atrial fibrillation risk in patients with typical atrial flutter has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Atrial Flutter

Snippet

Sponsor: University of Pennsylvania | Conditions: Typical Atrial Flutter, Risk Factors With Future Development of Atrial Flutter | NA | Status: WITHDRAWN